VERTEX PHARMACEUTICALS INCORPORATED
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 18 of its records are shown together here.
These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
CGCN GROUP, LLC | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
MARSHALL & POPP, LLC | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
MCLARTY INBOUND LLC | $90,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
AVENUE SOLUTIONS | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
TARPLIN, DOWNS & YOUNG, LLC | $80,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
ALSTON & BIRD LLP | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
STANTON PARK GROUP | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
ALB SOLUTIONS | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
TIBER CREEK GROUP | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
EMPIRE CONSULTING GROUP | $50,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED In-house | 75 | $36,200,000 |
| TARPLIN, DOWNS & YOUNG, LLC | 75 | $4,820,000 |
| TIBER CREEK GROUP | 63 | $3,970,000 |
| STANTON PARK GROUP | 66 | $2,970,000 |
| WILLIAMS AND JENSEN, PLLC | 34 | $990,000 |
| EMPIRE CONSULTING GROUP | 21 | $980,000 |
| AVENUE SOLUTIONS | 14 | $800,000 |
| CAPITOL COUNSEL LLC | 19 | $730,000 |
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | 13 | $550,000 |
| CGCN GROUP, LLC | 8 | $470,000 |
| CROSSROADS STRATEGIES, LLC | 14 | $440,000 |
| MARSHALL & POPP, LLC | 7 | $400,000 |
| MCLARTY INBOUND LLC | 7 | $290,000 |
| FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 5 | $210,000 |
| HOLLAND & KNIGHT LLP | 8 | $150,000 |
| ALB SOLUTIONS | 3 | $150,000 |
| SALT POINT STRATEGIES | 5 | $140,000 |
| ALSTON & BIRD LLP | 3 | $120,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 381 |
| Medicare/Medicaid | MMM | 211 |
| Budget/Appropriations | BUD | 143 |
| Taxation/Internal Revenue Code | TAX | 122 |
| Medical/Disease Research/Clinical Labs | MED | 65 |
| Pharmacy | PHA | 37 |
| Copyright/Patent/Trademark | CPT | 27 |
| Trade (domestic/foreign) | TRD | 20 |
| Defense | DEF | 15 |
| Veterans | VET | 4 |
| Science/Technology | SCI | 4 |
| Homeland Security | HOM | 1 |
| District of Columbia | DOC | 1 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 1227 | 119th | 59 |
| S. 475 | 119th | 49 |
| H.R. 6 | 114th | 42 |
| H.R. 3 | 116th | 29 |
| S. 2543 | 116th | 29 |
| H.R. 5376 | 117th | 27 |
| S. 2030 | 114th | 23 |
| H.R. 1319 | 117th | 21 |
| H.R. 7142 | 118th | 19 |
| S. 3832 | 118th | 19 |
| H.R. 748 | 116th | 18 |
| H.R. 3 | 117th | 16 |
| H.R. 19 | 117th | 15 |
| H.R. 460 | 113th | 15 |
| S. 1895 | 116th | 13 |
| H.R. 1628 | 115th | 13 |
| H.R. 604 | 116th | 12 |
| H.R. 9 | 114th | 12 |
| H.R. 2113 | 116th | 10 |
| H.R. 3204 | 113th | 10 |
| H.R. 3974 | 111th | 10 |
| H.R. 2430 | 115th | 9 |
| H.R. 1 | 115th | 9 |
| H.R. 7667 | 117th | 8 |
| S. 4348 | 117th | 8 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.